Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Dillon

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Scottish Medical Journal|April 28, 1999
The proof of the pudding. The first 165 liver transplants in the Scottish Liver Transplant UnitJ F Dillon
Journal of Viral Hepatitis|September 11, 2004
Hepatitis C: What is the best treatment?J F Dillon
Journal of Applied Microbiology|April 24, 2007
Microbial biofilms in the human gastrointestinal tractS Macfarlane, J F Dillon
The American Journal of Gastroenterology|August 1, 1994
Idiopathic hypereosinophilic syndrome presenting as intrahepatic cholestatic jaundiceJ F Dillon, N D Finlayson
Alimentary Pharmacology & Therapeutics|December 22, 2017
Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLDP N Brennan, J F Dillon
Alimentary Pharmacology & Therapeutics|May 21, 2016
Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradicationJ D Leask, J F Dillon
Bailliere'S Clinical Gastroenterology|December 1, 1995
EndoscopyJ F Dillon, P C Hayes
Alimentary Pharmacology & Therapeutics|December 21, 2012
Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markersM H Miller, J F Dillon
Alimentary Pharmacology & Therapeutics|April 5, 2013
Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?J C M Paterson, J F Dillon
Drug and Alcohol Dependence Reports|March 20, 2026
More than a medication: The lived meaning and value of long-acting injectable buprenorphineS R Donaldson, J F Dillon, A Radley
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Scottish Medical Journal|April 28, 1999
The proof of the pudding. The first 165 liver transplants in the Scottish Liver Transplant UnitJ F Dillon
Journal of Viral Hepatitis|September 11, 2004
Hepatitis C: What is the best treatment?J F Dillon
Journal of Applied Microbiology|April 24, 2007
Microbial biofilms in the human gastrointestinal tractS Macfarlane, J F Dillon
The American Journal of Gastroenterology|August 1, 1994
Idiopathic hypereosinophilic syndrome presenting as intrahepatic cholestatic jaundiceJ F Dillon, N D Finlayson
Alimentary Pharmacology & Therapeutics|December 22, 2017
Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLDP N Brennan, J F Dillon
Alimentary Pharmacology & Therapeutics|May 21, 2016
Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradicationJ D Leask, J F Dillon
Bailliere'S Clinical Gastroenterology|December 1, 1995
EndoscopyJ F Dillon, P C Hayes
Alimentary Pharmacology & Therapeutics|December 21, 2012
Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markersM H Miller, J F Dillon
Alimentary Pharmacology & Therapeutics|April 5, 2013
Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?J C M Paterson, J F Dillon
Drug and Alcohol Dependence Reports|March 20, 2026
More than a medication: The lived meaning and value of long-acting injectable buprenorphineS R Donaldson, J F Dillon, A Radley
Pageof 7